Abstract

Background & Objectives:The Chikungunya virus (CHIKV) transmitted to the humans through Aedes species of the mosquitoes. In December 2016, a severe outbreak reported from Pakistan. However, there is no vaccine or anti-viral treatment currently available so host immune response against CHIKV gained significant interest. Therefore, this study was conducted to identify the mutations in CHIKV E2 region of currently circulating Pakistani strains & determine their potential immunogenicity in Pakistani population.Methods:It was a cross sectional study in which a total of 60 CHIKV PCR positive samples were collected from Molecular Department of Pathology, Dow University of Health Sciences (DUHS), Karachi during November 2017 to February 2018. CHIKV E2 gene was amplified by PCR & sequenced. Sequences were analyzed by using bioinformatic tools followed by epitope prediction in E2 sequences by In-silico immunoinformatic approach.Results:Several single nucleotide variations (SNVs) were identified in Pakistani isolates with six novel mutations in E2 sequences. Immunoinformatic analyses showed more proteasomal sites, CTL & B-Cell epitopes in Pakistani strains with respect to S27 prototype with 69.4% population coverage against these epitopes in Pakistan. The study also identified key mutations responsible for generation of unique epitopes and HLA restriction in Pakistani isolates. The strain specific mutations revealed the current outbreak was caused by ESCA.IOL lineage of CHIKV.Conclusion:The evolution of E2 protein in Pakistani strains has increased its immunogenicity in comparison to ancestral s27 strain. The identification of most immunogenic and conserved epitopes with high population coverage has high potential to be used in vaccine development against these local strains.

Highlights

  • Chikungunya virus (CHIKV) is single stranded positive sense RNA arbovirus which is transmitted through Aedes spp. of mosquitoes

  • This study was conducted to identify the mutations in CHIKV E2 region of currently circulating Pakistani isolates & determine their potential immunogenicity in Pakistani population. It was a cross sectional study approved from Institutional Review Board of Dow University of Health Sciences (DUHS) (Ref: IRB1210/DUHS/Approval/2019, Dated: 19/02/19) total of 60 CHIKV positive serum samples were collected from Molecular Pathology Section DUHS during November 2017 to February 2018

  • Chikungunya virus E2 mutations in Pakistani isolates was successfully amplified & sequenced from 30 patients only as other samples were not amplified possibly due to low viral load in the sample

Read more

Summary

Introduction

CHIKV is single stranded positive sense RNA arbovirus which is transmitted through Aedes spp. of mosquitoes. It was first isolated from Tanzania in 1953.1 Approximately 50%-97% of patients develop symptoms including acute fever and persistent arthralgia in the chronic phase. This study was conducted to identify the mutations in CHIKV E2 region of currently circulating Pakistani strains & determine their potential immunogenicity in Pakistani population. Results: Several single nucleotide variations (SNVs) were identified in Pakistani isolates with six novel mutations in E2 sequences. The study identified key mutations responsible for generation of unique epitopes and HLA restriction in Pakistani isolates. The identification of most immunogenic and conserved epitopes with high population coverage has high potential to be used in vaccine development against these local strains

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.